Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational

Olufunso W Odunukan1, Matthew J Price1

  • 1Division of Cardiovascular Diseases, Scripps Clinic, 9898 Genesee Avenue, La Jolla, CA 92037, USA.

Insights

Patent foramen ovale (PFO) is common in cryptogenic stroke patients. This review assesses PFO closure

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Cryptogenic strokes account for about one-third of all strokes.
  • Patent foramen ovale (PFO) is found in up to 60% of cryptogenic stroke patients, a higher prevalence than in the general population.
  • Potential mechanisms for stroke in PFO patients include paradoxical embolism and in situ thrombosis.

Purpose of the Study:

  • To review and critically evaluate current research.
  • To assess the efficacy and safety of patent foramen ovale closure.
  • To determine the role of PFO closure in preventing recurrent cryptogenic strokes.

Main Methods:

  • Systematic review and critical appraisal of contemporary studies.
  • Analysis of data on PFO closure procedures.
  • Evaluation of stroke recurrence rates and safety outcomes post-closure.

Main Results:

  • Studies indicate a significant association between PFO and cryptogenic stroke.
  • Efficacy data on PFO closure for stroke prevention is being actively investigated.
  • Safety profiles of PFO closure interventions are a key consideration.

Conclusions:

  • Patent foramen ovale closure is a potential strategy for preventing recurrent cryptogenic strokes.
  • Further research is needed to definitively establish the efficacy and optimal patient selection for PFO closure.
  • Balancing the benefits of stroke prevention against procedural risks is crucial.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
406
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
309
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
367
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K